Clinical Trial

Marine Oil on Indirect Markers of Muscle Damage and Soreness

Study Description

Effectiveness of Two Different Forms of Marine Oil on Indirect Markers of Muscle Damage and Soreness in Untrained Men

To evaluate the effects of PCSO-524AR, and a blend of PCSO-24AR (75%) and krill oil (25%) (ESPO-572AR), on indirect markers of muscle damage, inflammation and soreness during recovery from muscle damaging exercise in untrained men.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Dietary Supplement - ESPO-572®

ESPO-572® is the same as PCSO-524®, except it has krill oil added to it.

Dietary Supplement - PCSO-524®

PCSO-524® (Lyprinol®/Omega XL®) is a nutritional supplement containing a patented extract of highly condensed form of stabilized marine lipids from the New Zealand green lipped mussel (Perna canaliculus) that is combined with olive oil and vitamin E. This marine oil lipid and omega-3 polyunsaturated fatty acid (PUFA) blend is a diverse mixture of sterol esters, sterols, polar lipids, triglycerides, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (split between the triacylglycerol a ...read more on ClinicalTrials.org

Additional Information

Official Study Title

Effectiveness of Two Different Forms of Marine Oil, Derived From the New Zealand Green Lipped Mussel and Krill Oil, on Indirect Markers of Muscle Damage and Soreness During Recovery From Muscle Damaging Exercise in Untrained Men

Clinical Trial ID

NCT03760757

ParticipAid ID

azpqrd